Table 1.
Characteristic | Control Group | Diabetes Group | P |
---|---|---|---|
Age, y | 59.2 ± 7.1 | 61.2 ± 5.1 | .23 |
Race/ethnicity | |||
White | 40 | 33 | |
Hispanic | 23 | 20 | .73 |
African American | 37 | 47 | |
Height, cm | 177.2 ± 6.3 | 175.2 ± 5.9 | .44 |
Weight, kg | 86.0 ± 16.8 | 92.9 ± 16.8 | .12 |
BMI | 27.6 ± 4.8 | 30.3 ± 4.9 | .04 |
Most recent serum glucose level, mg/dL | 95 ± 12 | 163 ± 98 | <.01 |
Hemoglobin A1c level, % | 5.5 ± 0.3 | 7.9 ± 1.6 | <.01 |
Active smoking | 17 | 23 | .75 |
Antibiotic use in prior 12 mo | 30 | 30 | 1.00 |
Known skin condition | 23 | 23 | 1.00 |
History of malignancy | 20 | 13 | .73 |
Vascular disease | 10 | 23 | .3 |
Statin use | 30 | 77 | <.01 |
NSAID use | 30 | 57 | .12 |
Time since last shower, h | 12.2 ± 10.8 | 8.4 ± 10.2 | .17 |
High temperature on sampling day, °C | 15.8 ± 5.2 | 18.2 ± 7.6 | .16 |
Data are no. of subjects or mean ± SD.
Abbreviations: BMI, body mass index (defined as the weight in kilograms divided by the height in square meters); NSAID, nonsteroidal antiinflammatory drug.